Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Patent intelligence tools, including those provided by DrugPatentWatch, now need to answer a different question: not just when does exclusivity expire, but what is the viable cost-plus entry price for this molecule, and how does that price compare to current protected pricing
Semaglutide, a leading GLP-1 receptor agonist, demonstrated a mean weight loss of 14.9% at weekly doses of 2.4 mg, compared with only 2.4% for placebo
PubMed PMID: 21104130
Cell Metabolism 2015 Lee et al
Can You Combine Both
It is a growth hormone-releasing peptide, meaning it is discussed for its ability to stimulate growth hormone secretion
US$ 20.50
US$ 25.95
US$ 25.95
US$ 29.29
US$ 24.66
